Immediate Effects of TENS and HVPS on Subacromial Pain and Shoulder Movements

Shoulder Pain Chronic Clinical Trial

Official title:

Immediate Effects of Transcutaneous Electrical Nerve Stimulation and High Voltage Pulsed Stimulation on Subacromial Pain and Shoulder Movements

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03588143
• Other study ID #: 16/044
• Status: Completed
• Phase: N/A
• Start date: November 2015
• Est. completion date: January 2017

Study information

• Verified date: July 2018
• Source: Mugla Sitki Koçman University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study was performed to investigate the immediate effects of transcutaneous electrical nerve stimulation (TENS) and high voltage pulsed stimulation (HVPS) on resting pain and pain-free range of shoulder motion (pfROM) in patients with subacromial pain syndrome (SAPS).

Description:

Transcutaneous electrical stimulation (TENS) and high voltage pulsed current/stimulation (HVPS) are both electrotherapeutic agents which can be used for pain relief in musculoskeletal conditions. Standard TENS devices usually deliver biphasic pulsed currents with a pulse duration between 50 μs and 1000 μs and pulse frequencies between 1 and 250 pps. HVPS devices are TENS-like devices which deliver direct current with twin monophasic spiked pulses of 10-500 V (500-ohm load) with a short pulse duration (microseconds). In both conventional TENS technique and HVPS for pain relief, the aim is to activate spinal gating mechanism by selectively stimulating large diameter Aβ fibers. Theoretically, high-frequency (~10-250 pps), low-intensity (nonpainful) currents are most efficient in selectively activating Aβ fibers, which is practically recognized by the user reporting 'strong but comfortable' nonpainful electrical paresthesia beneath the electrodes. There is no available evidence for the efficacy of TENS in patients with subacromial pain. Also, there has been little experimental work on the effects of HVPS on pain relief in the literature, as well as no known study for its efficacy in SAPS.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 106
• Est. completion date: January 2017
• Est. primary completion date: January 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• 18-65 years-old

• Pain with active shoulder movements

• Subacromial pain for 2 weeks-2 months

• Positive Hawkins-Kennedy and painful arc tests, infraspinatus weakness; in addition to these, for patients with partial rotator cuff tear, a negative drop-arm test

• Neer stage 1-2

Exclusion Criteria:

• Radiologically confirmed malignity

• Acromial/acromioclavicular arthritis

• History of fracture or surgery in the affected shoulder-arm complex

• Clinically confirmed polyarthritis, rheumatoid arthritis, fibromyalgia, adhesive capsulitis or osteoarthritis of glenohumeral joint or subacromial region

• Cervical/thoracal spinal problem• Neurological problems which may affect upper extremity movements or pain perception (stroke, peripheral neuropathy, brachial plexus lesion, etc.)

• Neer stage 3 and indication for surgery

• Usage of analgesic medication

• Obesity (Body mass =30 kg/m2)

• Contraindications for TENS or HVPS

• Previous experience with electrophysical agents or physiotherapy

• Pregnancy

Related Conditions & MeSH terms

• Shoulder Pain
• Shoulder Pain Chronic

Intervention

Device:
• Electrical stimulation
Two kinds of electrical stimulation (TENS and HVPS) and placebo intervention

Locations

Country	Name	City	State
n/a

Sponsors (2)

Lead Sponsor	Collaborator
Mehmet Gürhan KARAKAYA	Mugla Sitki Koçman University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change of pain-free shoulder range of motion	Pain-free ranges of active shoulder flexion, abduction, internal and external rotation were measured by a digital inclinometer (Baseline Digital Inclinometer, 2008 New York-USA), which was calibrated on a flat surface before each measurement. All evaluations were performed before and after each modality application. All of the measurements were performed by a physiotherapist blinded to the modalities applied (placebo/TENS/HVPS).	Change of pain-free shoulder range of motions from baseline at the end of 30 minutes of each intervention
Secondary	Change of pain intensity	The participants were asked to mark their resting pain intensity on a 0-10 cm visual analogue scale (VAS), where 0 cm indicated no pain and 10 cm indicated unbearable pain. The distance of the marked point from zero point was recorded as the intensity of pain. All evaluations were performed before and after each modality application. All of the measurements were performed by a physiotherapist blinded to the modalities applied (placebo/TENS/HVPS).	Change of pain intensity from baseline at the end of 30 minutes of each intervention